EUVIMEDEUVIMED entdecken
Crossref

Elucidating the Binding Mechanism of Oclacitinib With Bovine Serum Albumin: A Multidisciplinary Approach Combining Spectroscopy, Thermodynamics, and Molecular Docking

Dong Chen, Hui Gu, Jia-Ping Huang, Yu-Ting Wu, Rong-Juan Zhang, Shao-Liang Jiang iD, Jie-Hua Shi

Luminescence · 2025

DOI: 10.1002/bio.70244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Luminescence, 2025. Verfasst von Dong Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutic Science, Zhejiang University of Technology, Hangzhou, China. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Serum Albumin, Bovine, Sulfonamides, Pyrimidines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Zhejiang Hengyu Biol Technol Co. Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper elucidates the in vitro binding of oclacitinib (OLTN) with BSA through a multifaceted approach that combines experimental methodologies and theoretical computations. Spectroscopic analyses reveal that OLTN significantly attenuates the intrinsical fluorescence of BSA through the formation of an OLTN–BSA complex, indicating a static quenching mechanism. Experimental data further confirmed the formation of a nonfluorescent OLTN–BSA complex. These findings provide valuable insights into the molecular interactions governing the OLTN–BSA system, enhancing our understanding of drug–protein binding dynamics. The binding constant and stoichiometric ratio of the complex were determined to be approximately 10 4 M −1 and 1:1, respectively, suggesting moderate binding affinity of OLTN for BSA. Molecular docking assays verified that OLTN primarily associated with the Sudlow's Site II, inducing conformational alterations in both the secondary structure and quaternary structure of BSA. Thermodynamic and molecular docking analyses established that hydrophobicity interactions and hydrogen bonding (including conventional hydrogen bonding and the carbon hydrogen bonding) serve as the dominant driving forces for stabilizing the complex. This investigation provides critical guidance for understanding the pharmacodynamics and pharmacokinetics of OLTN in human, particularly regarding its plasma protein binding behavior and potential drug–drug interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationSerum Albumin, BovineSulfonamidesPyrimidinesThermodynamicsCattleAnimalsProtein BindingSpectrometry, FluorescenceBinding SitesMolecular StructureHydrogen BondingHumans

Stichwörter der Autor:innen

binding affinitybovine serum albumindrug–protein interactionmolecular dockingoclacitinib

Substanzen

Serum Albumin, BovineSulfonamidesPyrimidines

Autor:innen und Institutionen

  • College of Pharmaceutic Science, Zhejiang University of Technology, Hangzhou, China.

ORCID-Profile: Shao-Liang Jiang

Förderung

  • Zhejiang Hengyu Biol Technol Co. Ltd

Zitieren

APA

Chen, D., Gu, H., Huang, J. P., Wu, Y. T., Zhang, R. J., Jiang, S. L., & Shi, J. H. (2025). Elucidating the Binding Mechanism of Oclacitinib With Bovine Serum Albumin: A Multidisciplinary Approach Combining Spectroscopy, Thermodynamics, and Molecular Docking. Luminescence. https://doi.org/10.1002/bio.70244

Vancouver

Chen D, Gu H, Huang JP, Wu YT, Zhang RJ, Jiang SL, et al. Elucidating the Binding Mechanism of Oclacitinib With Bovine Serum Albumin: A Multidisciplinary Approach Combining Spectroscopy, Thermodynamics, and Molecular Docking. Luminescence. 2025. doi:10.1002/bio.70244

BibTeX
@article{Chen2025,
  author = {Chen, Dong and Gu, Hui and Huang, Jia-Ping and Wu, Yu-Ting and Zhang, Rong-Juan and Jiang, Shao-Liang and Shi, Jie-Hua},
  title = {Elucidating the Binding Mechanism of Oclacitinib With Bovine Serum Albumin: A Multidisciplinary Approach Combining Spectroscopy, Thermodynamics, and Molecular Docking},
  journal = {Luminescence},
  year = {2025},
  doi = {10.1002/bio.70244}
}
Kostenlos starten →